PET/CT and Occult Primary Tumors

Within the past 5 years, F-18 fluorodeoxyglucose (FDG) PET/CT has become one of the more frequent imaging modalities in the management of patients with cancer of unknown primary origin. FDG PET/CT detects more sites of metastasis than other modalities, and in 20% to 40% of cases it discloses the site of the primary tumor. Its exact role is yet to be defined because of a lack of prospective clinical trials comparing the performance of PET/CT with conventional anatomic imaging modalities. This article reviews the available literature, attempts to place PET/CT using F-18–labeled FDG in clinical perspective and compares the combined modality with conventional anatomic imaging technologies.

If the inline PDF is not rendering correctly, you can download the PDF file here.

Dr. Podoloff is a consultant, serves on the advisory board for PET/CT, and is a member of Academic Council for GE Healthcare. Correspondence: Donald A. Podoloff, MD, The University of Texas M. D. Anderson Cancer Center, Division of Diagnostic Imaging, 1515 Holcombe Boulevard, Unit 0057, Houston, TX 77030. E-mail: dpodoloff@di.mdacc.tmc.edu
  • 1

    PavlidisNBriasoulisEHainsworthJGrecoFA. Diagnostic and therapeutic management of cancer of an unknown primary. Eur J Cancer2003;39:19902005.

    • Search Google Scholar
    • Export Citation
  • 2

    GolderWA. Lymph node diagnosis in oncologic imaging: a dilemma still waiting to be solved. Onkologie2004;27:194199.

  • 3

    DontaTSSmokerWR. Head and neck cancer: carcinoma of unknown primary. Top Magn Reson Imaging2007;18:281292.

  • 4

    BasuSAlaviA. FDG-PET in the clinical management of carcinoma of unknown primary with metastatic cervical lymphadenopathy: shifting gears from detecting the primary to planning therapeutic strategies. Eur J Nucl Med Mol Imaging2007;34:427428.

    • Search Google Scholar
    • Export Citation
  • 5

    Guntinas-LichiusOPeter KlussmannJDinhS. Diagnostic work-up and outcome of cervical metastases from an unknown primary. Acta Otolaryngol2006;126:536544.

    • Search Google Scholar
    • Export Citation
  • 6

    GutzeitAAntochGKuhlH. Unknown primary tumors: detection with dual-modality PET/CT—initial experience. Radiology2005;234:227234.

  • 7

    Kolesnikov-GauthierHLevyEMerletP. FDG PET in patients with cancer of an unknown primary. Nucl Med Commun2005;26:10591066.

  • 8

    MevioEGoriniESbroccaM. The role of positron emission tomography (PET) in the management of cervical lymph nodes metastases from an unknown primary tumor. Acta Otorhinolaryngologica Italica2004;24:342347.

    • Search Google Scholar
    • Export Citation
  • 9

    MillerFRHusseyDBeeramM. Positron emission tomography in the management of unknown primary head and neck carcinoma. Arch Otolaryngol Head Neck Surg2005;131:626629.

    • Search Google Scholar
    • Export Citation
  • 10

    NanniCRubelloDCastellucciP. Role of 18F-FDG PET-CT imaging for the detection of an unknown primary tumor: preliminary results in 21 patients. Eur J Nucl Med Mol Imaging2005;32:589592.

    • Search Google Scholar
    • Export Citation
  • 11

    PaulSAStoeckliSJvon SchulthessGK. FDG PET and PET/CT for the detection of the primary tumor in patients with cervical non-squamous cell carcinoma metastasis of an unknown primary. Eur Arch Otorhinolaryngol2007;264:189195.

    • Search Google Scholar
    • Export Citation
  • 12

    ScottCLKudabaIStewartJM. The utility of 2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography in the investigation of patients with disseminated carcinoma of unknown primary origin. Mol Imaging Biol2005;7:236243.

    • Search Google Scholar
    • Export Citation
  • 13

    StoeckliSJMosna-FirlejczykKGoerresGW. Lymph node metastasis of squamous cell carcinoma from an unknown primary: impact of positron emission tomography. Eur J Nucl Med Mol Imaging2003;30:411416.

    • Search Google Scholar
    • Export Citation
  • 14

    WongWLSaundersM. The impact of FDG PET on the management of occult primary head and neck tumours. Clin Oncol (R Coll Radiol)2003;15:461466.

    • Search Google Scholar
    • Export Citation
  • 15

    Delgado-BoltonRCFernandez-PerezCGonzalez-MateACarrerasJL. Meta-analysis of the performance of 18F-FDG PET in primary tumor detection in unknown primary tumors. J Nucl Med2003;44:13011314.

    • Search Google Scholar
    • Export Citation
  • 16

    SevePBilloteyCBroussolleC. The role of 2-deoxy-2-[F-18] fluoro-D-glucose positron emission tomography in disseminated carcinoma of unknown primary site. Cancer2007;109:292299.

    • Search Google Scholar
    • Export Citation
  • 17

    AlberiniJLBelhocineTHustinxR. Whole-body positron emission tomography using fluorodeoxyglucose in patients with metastases of unknown primary tumors (CUP syndrome). Nucl Med Commun2003;24:10811086.

    • Search Google Scholar
    • Export Citation
  • 18

    FenclPBelohlavekOSkopalovaM. Prognostic and diagnostic accuracy of [18F]FDG-PET/CT in 190 patients with carcinoma of unknown primary. Eur J Nucl Med Mol Imaging2007;34:17831792.

    • Search Google Scholar
    • Export Citation
  • 19

    FreudenbergLSRosenbaum-KrummeSJBockischA. Cancer of unknown primary. Recent Results Cancer Res2008;170:193202.

  • 20

    GarinEPrigent-LejeuneFLesimpleT. Impact of PET-FDG in the diagnosis and therapeutic care of patients presenting with metastases of unknown primary. Cancer Invest2007;25:232239.

    • Search Google Scholar
    • Export Citation
  • 21

    JohansenJBuusSLoftA. Prospective study of 18FDG-PET in the detection and management of patients with lymph node metastases to the neck from an unknown primary tumor. Results from the DAHANCA-13 study. Head Neck2008;30:471478.

    • Search Google Scholar
    • Export Citation
  • 22

    JoshiUvan der HoevenJJComansEF. In search of an unknown primary tumor presenting with extracervical metastases: the diagnostic performance of FDG-PET. Br J Radiol2004;77:10001006.

    • Search Google Scholar
    • Export Citation
  • 23

    MillerFRKarnadABEngT. Management of the unknown primary carcinoma: long-term follow-up on a negative PET scan and negative panendoscopy. Head Neck2008;30:2834.

    • Search Google Scholar
    • Export Citation
  • 24

    StoeckliSJMosna-FirlejczykKGoerresGW. Lymph node metastasis of squamous cell carcinoma from an unknown primary: impact of positron emission tomography. Eur J Nucl Med Mol Imaging2003;30:411416.

    • Search Google Scholar
    • Export Citation
  • 25

    WartskiMLe StancEGontierE. In search of an unknown primary tumor presenting with cervical metastases: performance of hybrid FDG-PET-CT. Nucl Med Commun2007;28:365371.

    • Search Google Scholar
    • Export Citation
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 24 24 5
PDF Downloads 10 10 7
EPUB Downloads 0 0 0